Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DepoCyte intrathecal chemotherapy versus no intrathecal therapy for leptomeningeal metastases from solid tumors
2007-000179-41Phase 3Terminated
- Sponsor
- Mundipharma
- Start
- Jun 2008
- Modality
- Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label trial of liposomal cytarabine in Carcinomatous Meningitis (CM) (2 arms), sponsored by Mundipharma. Primary endpoint: Neurological progression-free survival. Started Jun 2008; status: terminated.
02
Drugs
liposomal cytarabine
03
Conditions
Carcinomatous Meningitis (CM)
Beyond the preview
Go deeper on 2007-000179-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000179-41.